After a long weekend break and a three-week lull in momentum, the Indian stock market resumed trading today (April 15) with a flurry of action. From major sectoral developments to the kickoff of the earnings season, and a surprise tariff announcement by US President Donald Trump making waves globally. Here is a quick look at the key stocks that are in focus today.
Market recap
On Friday, April 11, Indian markets wrapped up the week on a high, with benchmark indices clocking sharp gains in a broad-based rally. The Sensex jumped 1,310 points, or 1.77%, to close at 75,157.26, while the Nifty surged 429 points, or 1.92%, ending at 22,828.55.
Stocks to watch on April 15, 2025
Macrotech Developers
The Lodha brothers- Abhishek and Abhinandan – have officially settled their differences, ending the long-standing brand name dispute. Going forward, Abhishek Lodha, who leads Macrotech Developers, will exclusively hold the rights to the ‘Lodha’ and ‘Lodha Group’ brand names. Abhinandan Lodha retains exclusive rights to his own brand, House of Abhinandan Lodha (HoABL).
Dr. Reddy’s Laboratories
Dr Reddy’s Laboratories found itself at the centre of a workforce rumour this week. A media report claimed the company was slashing 25% of its employee-related costs. But the pharma giant strongly denied it, calling the report “factually incorrect” in a formal stock exchange filing.
Reliance Industries
Mukesh Ambani-led Reliance Industries is slowly, steadily increasing its footprint in the shipping business. It recently picked up an additional 10% stake in Nauyaan Shipyard Private Ltd, taking its commitment to the sector a notch higher. The stake was bought for Rs 1.72 crore via a subsidiary arm.
Vedanta
Vedanta is once again facing regulatory heat, this time in Odisha. The state’s Pollution Control Board has slapped a Rs 71.16 crore penalty for allegedly mismanaging fly ash. Vedanta, however, is not staying silent. The company has disputed the charges and plans to take legal steps, saying the penalty overlooks its compliance record.
Zydus Lifesciences
Zydus Lifesciences has some good news — it has received final USFDA approval to sell Jaythari (Deflazacort) Tablets in America. This drug helps treat Duchenne muscular dystrophy (DMD) — a rare condition that causes muscle weakness and degeneration, often seen in children. The company can now launch a generic version of Emflaza in four different strengths.
SBI
After the RBI’s policy rate cut, the State Bank of India has reduced its Repo Linked Lending Rate (RLLR) by 25 basis points, bringing it down to 8.25%.
Delhivery
Sahil Barua, co-founder and CEO of logistics giant Delhivery, has resigned from the board of Swiggy. His exit was formally recorded by Swiggy on April 11. While he remains at the helm of Delhivery, Barua’s departure marks a quiet shift in Swiggy’s board dynamics.
JK Cement
Cement major JK Cement is considering raising Rs 500 crore through private placement of non-convertible debentures (NCDs). The board will meet on May 24 to discuss the plan. If approved, the fundraising proposal will be presented to shareholders at the upcoming 31st annual general meeting.
Persistent Systems
Persistent Systems is merging its fully-owned subsidiary, Capiot Software, into the parent company. The National Company Law Tribunal (NCLT) gave the green light recently.
HCL Tech
In the tech world, HCL Tech is on a roll. It just earned three new Google Cloud Partner specialisations in generative AI services, cloud migration, and infrastructure modernisation